Clinical Trial Update: Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation [NA]

View source ↗

Summary

This clinical trial compares pulsed field ablation to anti-arrhythmic drug therapy as a first-line treatment for persistent atrial fibrillation. The study is ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING